NIH-funded research R01 grant

Stretch-Activated Signaling in the Human Uterus to Help Prevent Preterm Birth

Official title: Stretch-Activated Signaling in Human Myometrium to Prevent Preterm Birth

Funded at University of Nevada Reno · NIH-11285017 · Data updated 2026-11-12

A science team is studying how the human uterus relaxes in order to delay or prevent preterm birth, with a focus on making therapies safer and more effective for pregnant people, especially African American communities.

More Preterm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Nevada Reno
NIH-funded
Lab location1 site (Reno, United States)
Project startSeptember 10, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$609,718
NIH project number1R01HD117973-01A1
Project IDNIH-11285017 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people at risk for preterm birth, particularly those in populations with higher PTB rates.

Less likely to help

Individuals not at risk for preterm birth or who do not carry the specific myometrial signaling characteristics studied may see no direct benefit.

What this research studies

This project looks at stretch-activated signaling in the human myometrium to understand why current tocolytics often fail and to identify new approaches to prevent preterm birth. Researchers will study how the uterine smooth muscle responds to stretching and how this could be targeted to maintain pregnancy safely. The work uses human tissue and relevant models to uncover signaling pathways that could lead to better, more reliable tocolytic strategies. By focusing on unique myometrial biology, the study aims to reduce disparities in preterm birth outcomes.

Why it matters

Potential benefit: If successful, the research could lead to safer and more effective ways to prevent preterm birth, potentially reducing complications for newborns and improving maternal health.

How similar studies have gone: Past studies have explored myometrial signaling and tocolytics, but this project seeks novel, human-specific pathways that could offer improved outcomes.

Where this research is happening

  • University of Nevada Reno
    Reno, United States
    Active

Researchers

  • Principal investigator: Barnett, Scott Danielson — University of Nevada Reno
  • Study coordinator: Barnett, Scott Danielson

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.